DNAprint Genomics (DNAG)

[IVRT]

DNAPRINT GENOMICS ANNOUNCES MERGER

SARASOTA, FL., Oct. 17, 2000 - DNAPrint genomics, Inc., (Pink
Sheets: DNAP), today announced that it has merged with an SEC
12g full reporting company, SDE Holdings 1, Inc., after acquiring all
of the issued and outstanding stock of SDE. The merger allows
DNAPrint genomics, Inc. to file its 211 application with the NASD as
a successor full reporting company to become listed on the OTC
Bulletin Board. DNAPrint expects to file its 8-k 12g3 within the next
few days, and will apply to the NASD immediately after that filing.

ABOUT DNAPRINT GENOMICS, INC.
DNAPrint genomics, Inc. provides practitioners of genomic research
and personalized medicine with a comprehensive system for
complex trait dissection and patient classification. DNAPrint
genomics Inc. was founded by a group of scientists with research
and commercial experience in high-level mathematical modeling,
programming and molecular genetics. For more information about
the company, please visit www.dnaprint.com

For scientific inquiries please contact: Dr. Tony Frudakis at (941)
351-4543.

All other inquiries please contact: Richard Craig Hall at (941)
341-0136.

Except for factual statements made herein, the information contained
in this press release consists of forward-looking statements that
involve risks and uncertainties. The Company's actual results could
differ materially from those contained in such statements. Factors
that could cause or contribute to such differences include
unexpected shortages of critical components, rescheduling or
cancellation of customer orders, the timing and market acceptance
of new product introductions by the Company and its competitors,
and general competition and price pressures in the marketplace.


Copyright DNAprint genomics © 2000